OVXA fundamentals
Key facts
Ovoca Bio Plc is a clinical-stage biopharmaceutical company, which engages in the women's health, clinical development and commercial planning of BP-101, and novel treatment for women with hypoactive sexual desire disorder (HSDD). It operates through the following segments: Bio-pharmaceutical, Investment, and Administrative. The Bio-pharmaceutical segment covers activities that are carried out by IVIX LLC and OVB Australia Pty. The Investment segment represents activities carried out by Silver Star Limited, a subsidiary company located in Bermuda. The Administrative segment consists of the group administration costs. The company was founded on January 15, 1985 and is headquartered in Dublin, Ireland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company